Bio-Techne
TECH
NZ$84.50
Share price
-0.75%
Change (1 day)
-28.03%
Change (1 year)
Categories
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.
Bio-Techne (TECH) - Total debt
Total debt on the balance sheet as of March 2025 : NZ$0.69 Billion
According to Bio-Techne's latest financial reports the company's total debt is NZ$0.69 Billion. A company’s total debt is the sum of all current and non-current debts.
Bio-Techne - Total debt on balance sheet (from 1999 to 2025)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-06-30 | NZ$0.68 B | -7.27% |
| 2023-06-30 | NZ$0.74 B | 42% |
| 2022-06-30 | NZ$0.52 B | -13.1% |
| 2021-06-30 | NZ$0.60 B | -10.56% |
| 2020-06-30 | NZ$0.67 B | -10.56% |
| 2019-06-30 | NZ$0.75 B | 50.1% |
| 2018-06-30 | NZ$0.50 B | 6.61% |
| 2017-06-30 | NZ$0.46 B | 251.77% |
| 2016-06-30 | NZ$0.13 B | 17.62% |
| 2015-06-30 | NZ$0.11 B | 668.16% |
| 2014-06-30 | NZ$14.77 M | |
| 2006-06-30 | NZ$22.16 M | 3.75% |
| 2005-06-30 | NZ$21.36 M | -13.81% |
| 2004-06-30 | NZ$24.79 M | -15.52% |
| 2003-06-30 | NZ$29.34 M | -20.98% |
| 2002-06-30 | NZ$37.14 M | -20.26% |
| 2001-06-30 | NZ$46.57 M | 10.75% |
| 2000-06-30 | NZ$42.05 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | NZ$56.14 B | 7,972.98% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | NZ$2.24 B | 223.38% | 🇺🇸 USA |
 Becton Dickinson BDX | NZ$31.64 B | 4,450.19% | 🇺🇸 USA |
 Danaher DHR | NZ$27.06 B | 3,790.68% | 🇺🇸 USA |
 Qiagen QGEN | NZ$2.31 B | 232.55% | 🇳🇱 Netherlands |
 General Electric GE | NZ$32.14 B | 4,521.26% | 🇺🇸 USA |
 Enzo Biochem ENZB | NZ$4.93 M | -99.29% | 🇺🇸 USA |